Centrus Energy announced strong second-quarter financial and operational outcomes for 2026, highlighting significant progress across its primary markets: commercial Low-Enriched Uranium (LEU), national security initiatives, and High-Assay, Low-Enriched Uranium (HALEU). The company's total order backlog has surged to $4.5 billion, extending through 2040, bolstered by new commercial agreements and the successful fulfillment of financial conditions for contingent contracts. A pivotal achievement was securing a $900 million task order from the U.S. Department of Energy (DOE), marking a transition from technology demonstration to large-scale commercial production. Centrus is actively expanding its workforce and supply chain, anticipating the completion of its first centrifuge at the Oak Ridge facility by the end of 2026, underscoring its commitment to strengthening America's nuclear fuel supply chain.
Centrus Energy's President and CEO, Amir Vexler, emphasized the company's strong performance, attributing it to tailwinds across its key sectors. The increasing global demand for uranium enrichment services is significantly influenced by geopolitical factors, such as the impending Russian import ban, and the expansion of nuclear energy capabilities in Europe and Asia. Vexler detailed how the DOE's $900 million award is crucial for funding the company's ambitious centrifuge build-out program, providing a non-dilutive and non-debt source of capital that mitigates risks and supports job creation across the nation.
The company is witnessing robust demand in the commercial LEU market, fueled by global electricity growth and the ongoing operation of existing nuclear reactors. Regulatory changes proposed by the U.S. Nuclear Regulatory Commission (NRC) are expected to further stimulate industry growth by accelerating new nuclear capacity and reducing development costs. Internationally, countries like Sweden and the Netherlands are exploring new nuclear developments, while Belgium plans to reactivate dormant reactors. In Asia, the recommissioning of units like TEPCO's Kashiwazaki reactor exemplifies the rising demand. Furthermore, the government sector, including the National Nuclear Security Administration (NNSA), continues to signal strong demand for enriched uranium, recognizing Centrus's unique capability to meet national security requirements.
The HALEU market also presents significant growth opportunities, with a majority of advanced reactor designs relying on HALEU for their operations. Centrus has secured key agreements, including a letter of intent with Oklo and a definitive agreement with X-energy, to supply HALEU starting in 2029. These contracts often include prepayment clauses, offering a vital source of non-dilutive funding for Centrus's expansion efforts. The company is also proactively strengthening its supply chain by finalizing contracts with 75% of its critical suppliers to insulate against price fluctuations and stabilize costs. Internally, Centrus is implementing efficiency-driven initiatives, including collaborations with Palantir and EPC partners, to optimize manufacturing processes and reduce lead times.
Despite a 23% decrease in Separative Work Unit (SWU) volumes sold in the second quarter, the pricing environment remains favorable due to demand outstripping supply and a lack of new capacity additions in the near term. Centrus's financial results reflect a total revenue of $176.1 million, a 14% increase from the previous year, and a GAAP net income of $16.8 million. The company reported a cash position of $1.9 billion as of June 30, 2026, following opportunistic use of its at-the-market (ATM) program. Centrus has reaffirmed its full-year 2026 revenue guidance of $450 million to $500 million and increased its workforce guidance for the Piketon facility, reflecting confidence in its operational expansion and market position. The company is poised to continue its upward trajectory, contributing significantly to energy security and the nuclear fuel supply chain.
